Synthetic switch-based baculovirus for transgene expression control and selective killing of hepatocellular carcinoma cells

Abstract Baculovirus (BV) holds promise as a vector for anticancer gene delivery to combat the most common liver cancer–hepatocellular carcinoma (HCC). However, in vivo BV administration inevitably results in BV entry into non-HCC normal cells, leaky anticancer gene expression and possible toxicity. To improve the safety, we employed synthetic biology to engineer BV for transgene expression regulation. We first uncovered that miR-196a and miR-126 are exclusively expressed in HCC and normal cells, respectively, which allowed us to engineer a sensor based on distinct miRNA expression signature. We next assembled a synthetic switch by coupling the miRNA sensor and RNA binding protein L7Ae for translational repression, and incorporated the entire device into a single BV. The recombinant BV efficiently entered HCC and normal cells and enabled cis-acting transgene expression control, by turning OFF transgene expression in normal cells while switching ON transgene expression in HCC cells. Using pro-apoptotic hBax as the transgene, the switch-based BV selectively killed HCC cells in separate culture and mixed culture of HCC and normal cells. These data demonstrate the potential of synthetic switch-based BV to distinguish HCC and non-HCC normal cells for selective transgene expression control and killing of HCC cells.

[1]  Mingqi Xie,et al.  A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  Chi-Yuan Chen,et al.  Baculovirus as a gene delivery vector: Recent understandings of molecular alterations in transduced cells and latest applications , 2011, Biotechnology Advances.

[3]  Martin Fussenegger,et al.  From gene switches to mammalian designer cells: present and future prospects. , 2013, Trends in biotechnology.

[4]  Benedikt Klauser,et al.  Riboswitch-mediated Attenuation of Transgene Cytotoxicity Increases Adeno-associated Virus Vector Yields in HEK-293 Cells. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  Ron Weiss,et al.  Synthetic biology devices and circuits for RNA-based ‘smart vaccines’: a propositional review , 2015, Expert review of vaccines.

[6]  Shiaw-Min Hwang,et al.  Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation. , 2015, Biomaterials.

[7]  Linhong Deng,et al.  Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B , 2014, Cytotechnology.

[8]  Yaakov Benenson,et al.  A Workflow for In Vivo Evaluation of Candidate Inputs and Outputs for Cell Classifier Gene Circuits. , 2017, ACS synthetic biology.

[9]  Hirohisa Ohno,et al.  Designed Regular Tetragon-Shaped RNA-Protein Complexes with Ribosomal Protein L1 for Bionanotechnology and Synthetic Biology. , 2015, ACS nano.

[10]  A. Annoni,et al.  A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. , 2007, Blood.

[11]  Tomoaki Hara,et al.  Synthetic translational regulation by an L7Ae-kink-turn RNP switch. , 2010, Nature chemical biology.

[12]  Duško Lainšček,et al.  A Synthetic Mammalian Therapeutic Gene Circuit for Sensing and Suppressing Inflammation. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  Y. Suárez,et al.  MicroRNAs as novel regulators of angiogenesis. , 2009, Circulation research.

[14]  N. Cheshenko,et al.  A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus , 2001, Gene Therapy.

[15]  Morgan L. Maeder,et al.  Genome-editing Technologies for Gene and Cell Therapy , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  J. Keasling,et al.  Integrating Biological Redesign: Where Synthetic Biology Came From and Where It Needs to Go , 2014, Cell.

[17]  Hirohide Saito,et al.  Cell-type-specific genome editing with a microRNA-responsive CRISPR–Cas9 switch , 2017, Nucleic acids research.

[18]  Ru-Fang Yeh,et al.  miR-126 regulates angiogenic signaling and vascular integrity. , 2008, Developmental cell.

[19]  Jennifer A. Doudna,et al.  Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering , 2016, Cell.

[20]  Z. Dai,et al.  MiR-146a and miR-196a-2 polymorphisms are associated with hepatitis virus-related hepatocellular cancer risk: a meta-analysis , 2017, Aging.

[21]  Lindsay J. Georgopoulos,et al.  Evaluating Baculovirus as a Vector for Human Prostate Cancer Gene Therapy , 2013, PloS one.

[22]  Yu-Chen Hu,et al.  Enhanced critical-size calvarial bone healing by ASCs engineered with Cre/loxP-based hybrid baculovirus. , 2017, Biomaterials.

[23]  J. Keith Joung,et al.  High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.

[24]  Wen-Hsin Lo,et al.  Baculovirus vectors for antiangiogenesis-based cancer gene therapy , 2011, Cancer Gene Therapy.

[25]  G. Falco,et al.  Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells , 2016, Oncotarget.

[26]  A. Bosserhoff,et al.  MicroRNA miR‐196a controls melanoma‐associated genes by regulating HOX‐C8 expression , 2011, International journal of cancer.

[27]  Martin Fussenegger,et al.  Synthetic RNA-based switches for mammalian gene expression control. , 2017, Current opinion in biotechnology.

[28]  A. Wan,et al.  Microfibers Fabricated by Non‐Covalent Assembly of Peptide and DNA for Viral Vector Encapsulation and Cancer Therapy , 2012, Advanced materials.

[29]  Haiyang Xie,et al.  Donor miR‐196a‐2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population , 2016, International journal of cancer.

[30]  C. Smolke,et al.  Control of alphavirus-based gene expression using engineered riboswitches. , 2015, Virology.

[31]  Hirohide Saito,et al.  Synthetic human cell fate regulation by protein-driven RNA switches , 2011, Nature Communications.

[32]  R. Morgan,et al.  The Role of HOXB9 and miR-196a in Head and Neck Squamous Cell Carcinoma , 2015, PloS one.

[33]  T. Yen,et al.  The role of adipose-derived stem cells engineered with the persistently expressing hybrid baculovirus in the healing of massive bone defects. , 2011, Biomaterials.

[34]  M. Davis,et al.  Highly efficient baculovirus-mediated multigene delivery in primary cells , 2016, Nature Communications.

[35]  Liu Huang,et al.  Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma. , 2015, International journal of clinical and experimental pathology.

[36]  Christof von Kalle,et al.  Artificial riboswitches for gene expression and replication control of DNA and RNA viruses , 2014, Proceedings of the National Academy of Sciences.

[37]  Martin Fussenegger,et al.  A general design strategy for protein-responsive riboswitches in mammalian cells , 2014, Nature Methods.

[38]  Huimin Zhao,et al.  Engineering reprogrammable RNA-binding proteins for study and manipulation of the transcriptome. , 2015, Molecular bioSystems.

[39]  Chunxiao Wu,et al.  Combinatorial control of suicide gene expression by tissue-specific promoter and microRNA regulation for cancer therapy. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[40]  Koji Okamoto,et al.  Tumor‐derived spheroids: Relevance to cancer stem cells and clinical applications , 2017, Cancer science.

[41]  Ron Weiss,et al.  Mammalian synthetic circuits with RNA binding proteins delivered by RNA , 2015, Nature Biotechnology.

[42]  P. Schlag,et al.  Efficient gene transfer into human hepatocytes by baculovirus vectors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Prashant Mali,et al.  A multifunctional AAV–CRISPR–Cas9 and its host response , 2016, Nature Methods.

[44]  Shiaw-Min Hwang,et al.  Baculovirus-mediated miRNA regulation to suppress hepatocellular carcinoma tumorigenicity and metastasis. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[45]  Martin Fussenegger,et al.  Self-sufficient control of urate homeostasis in mice by a synthetic circuit , 2010, Nature Biotechnology.

[46]  Yu-Chen Hu,et al.  Healing of osteoporotic bone defects by baculovirus-engineered bone marrow-derived MSCs expressing MicroRNA sponges. , 2016, Biomaterials.

[47]  Markus Wieland,et al.  Programmable single-cell mammalian biocomputers , 2012, Nature.

[48]  M. Kay,et al.  Recombinant AAV as a platform for translating the therapeutic potential of RNA interference. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[49]  Christina D Smolke,et al.  Reprogramming Cellular Behavior with RNA Controllers Responsive to Endogenous Proteins , 2010, Science.

[50]  S. Haas,et al.  Synthetic riboswitches for external regulation of genes transferred by replication-deficient and oncolytic adenoviruses , 2012, Nucleic acids research.

[51]  R. Kotin,et al.  Baculovirus: an insect-derived vector for diverse gene transfer applications. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[52]  Chin-Yu Lin,et al.  Efficient gene delivery into cell lines and stem cells using baculovirus , 2014, Nature Protocols.

[53]  James J. Collins,et al.  A Tunable Genetic Switch Based on RNAi and Repressor Proteins for Regulating Gene Expression in Mammalian Cells , 2007, Cell.

[54]  S. Wilhelm,et al.  Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. , 2006, Cancer research.

[55]  H. Isom,et al.  Use of the Hepatitis B Virus Recombinant Baculovirus-HepG2 System to Study the Effects of (−)-β-2′,3′-Dideoxy-3′-Thiacytidine on Replication of Hepatitis B Virus and Accumulation of Covalently Closed Circular DNA , 1999, Antimicrobial Agents and Chemotherapy.

[56]  Shunsuke Kawasaki,et al.  Synthetic mRNA devices that detect endogenous proteins and distinguish mammalian cells , 2017, Nucleic acids research.

[57]  James A. Stapleton,et al.  Quantitative and simultaneous translational control of distinct mammalian mRNAs , 2013, Nucleic acids research.

[58]  Z. Dai,et al.  MiR ‐ 146 a and miR ‐ 196 a ‐ 2 polymorphisms are associated with hepatitis virus ‐ related hepatocellular cancer risk : a meta ‐ analysis , 2017 .

[59]  R. López-Romero,et al.  Heterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a. , 2014, International journal of clinical and experimental pathology.

[60]  Shiaw-Min Hwang,et al.  Enhanced and prolonged baculovirus-mediated expression by incorporating recombinase system and in cis elements: a comparative study , 2013, Nucleic acids research.

[61]  Jeroen Lammertyn,et al.  Putting RNA to work: Translating RNA fundamentals into biotechnological engineering practice. , 2015, Biotechnology advances.

[62]  James A. Stapleton,et al.  Feedback Control of Protein Expression in Mammalian Cells by Tunable Synthetic Translational Inhibition , 2011, ACS synthetic biology.

[63]  David V. Schaffer,et al.  Engineering adeno-associated viruses for clinical gene therapy , 2014, Nature Reviews Genetics.

[64]  Niko Beerenwinkel,et al.  Automated Design of Synthetic Cell Classifier Circuits Using a Two-Step Optimization Strategy. , 2017, Cell systems.

[65]  T. Yen,et al.  Adipose-derived stem cell sheets functionalized by hybrid baculovirus for prolonged GDNF expression and improved nerve regeneration. , 2017, Biomaterials.

[66]  David Victor,et al.  Hepatocellular carcinoma: a review , 2016, Journal of hepatocellular carcinoma.

[67]  Wen-Hsin Lo,et al.  Development of the hybrid Sleeping Beauty-baculovirus vector for sustained gene expression and cancer therapy , 2011, Gene Therapy.

[68]  T. Yen,et al.  Osteogenic differentiation of adipose-derived stem cells and calvarial defect repair using baculovirus-mediated co-expression of BMP-2 and miR-148b. , 2014, Biomaterials.

[69]  J. Niles,et al.  Synthetic RNA–protein modules integrated with native translation mechanisms to control gene expression in malaria parasites , 2016, Nature Communications.